Wall Street Analysts Predict a 26.18% Upside in Mirum Pharmaceuticals (MIRM): Here's What You Should Know

Mirum Pharmaceuticals, Inc. (MIRM) closed the last trading session at $49.93, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $63 indicates a 26.2% upside potential.The mean estimate comprises 10 short-term price targets with a standard deviation of $8.30. While the lowest estimate of $50 indicates a 0.1% increase from the current price level, the most optimistic analy ...